Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43902

1.
2.

PrEP works.

Jefferys R.

IAVI Rep. 2015;19(1):4-10, 19. No abstract available.

PMID:
26043498
3.

The diagnosis, management and prevention of HIV-associated tuberculosis.

Wasserman S, Meintjes G.

S Afr Med J. 2014 Dec;104(12):886-93. Review.

PMID:
26042273
4.

Management challenges in tuberculosis and HIV.

Meintjes G.

S Afr Med J. 2014 Dec;104(12):885. No abstract available.

PMID:
26042272
6.

Tricuspid valve endocarditis associated with intravenous nyoape use: a report of 3 cases.

Meel R, Peters F, Essop MR.

S Afr Med J. 2014 Dec;104(12):853-5.

PMID:
26042266
7.

HIV research for prevention--huge potential but no 'magic bullet'.

Bateman C.

S Afr Med J. 2014 Dec;104(12):838-9. No abstract available.

PMID:
26042258
8.

[A panel of the drug-resistance HIV-1 clinical isolates].

Nossik MN, Kiseleva IA, Bochkova MS, Ryzhov KA, Kravtchenko AV, Pokrovsky VV.

Vopr Virusol. 2015;60(1):24-7. Russian.

PMID:
26021069
9.

[Indicators of the human immunodeficiency virus drug resistance to antiretroviral drugs in HIV-infected individuals in the Siberian Federal District in 2010-2012].

Kolomeets AN, Dovgopolyuk ES, Sergeeva IV, Yastrebov VK, Tyumentsev AT.

Vopr Virusol. 2015;60(1):20-3. Russian.

PMID:
26021068
10.

Compare before deciding. Treatment of HIV infection.

[No authors listed]

Prescrire Int. 2014 Nov;23(154):263. No abstract available.

PMID:
25954792
11.

[Should pre-exposure prophylaxis be used to prevent HIV?].

Nau JY.

Rev Med Suisse. 2015 Mar 11;11(465):622-3. French. No abstract available.

PMID:
25946876
12.

Pre-exposure prophylaxis works--it's time to deliver.

Beyrer C, Bekker LG, Pozniak A, Barré-Sinoussi F.

Lancet. 2015 Apr 18;385(9977):1482-4. doi: 10.1016/S0140-6736(15)60724-3. No abstract available.

PMID:
25933264
13.

[Problems of early detection of HIV infection, medical and psychological support of HIV-infected soldiers].

Uliukin IM, Bolekhan VN, Iusupov VV, Bulan'kov IuI, Orlova ES.

Voen Med Zh. 2015 Jan;336(1):45-9. Russian.

PMID:
25916037
14.

Drug treatment for adults with HIV infection.

Samuel M, Winston A, Peters B.

BMJ. 2015 Apr 23;350:h1555. doi: 10.1136/bmj.h1555. No abstract available.

PMID:
25908648
15.

Synthesis and evaluation of novel 6-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.

Khalifa NM, Pedersen EB, Nielsen C, Al-Omar MA.

Bioorg Khim. 2014 Sep-Oct;40(5):629-35.

PMID:
25895358
16.

Socioepidemiologic profile and treatment-seeking behaviour of HIV/AIDS patients in a tertiary-care hospital in south India.

Balasundaram A, Sarkar S, Hamide A, Lakshminarayanan S.

J Health Popul Nutr. 2014 Dec;32(4):587-94.

17.

Evaluation of the occurrence and type of antiretroviral and opportunistic infection medication errors within the inpatient setting.

Chiampas TD, Kim H, Badowski M.

Pharm Pract (Granada). 2015 Jan-Mar;13(1):512. Epub 2015 Mar 15.

18.

Smart nanoparticles as targeting platforms for HIV infections.

Adhikary RR, More P, Banerjee R.

Nanoscale. 2015 May 7;7(17):7520-34. doi: 10.1039/c5nr01285f.

PMID:
25874901
19.

Mannose-specific lectins that inhibit HIV infection bind nonspecifically to HIV Env-expressing cells.

Chau D, Yee M, Gebremedhin S, Cheung J, Chino T, Düzgüneş N.

J Calif Dent Assoc. 2015 Feb;43(2):93-6.

PMID:
25868224
20.

The changing role of HIV-associated oral candidiasis in the era of HAART.

Patuwo C, Young K, Lin M, Pardi V, Murata RM.

J Calif Dent Assoc. 2015 Feb;43(2):87-92. Review.

PMID:
25868223
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk